AMN's investment validates our unique approach to improving efficiency in our healthcare system and to get measurable and enhanced quality of care for patients through the use of cutting-edge technology, said Brian J. Roberts, President of PipelineRx. With AMN's workforce solutions staffing and knowledge services leadership, we look forward to what we can accomplish together to greatly help hospitals achieve financial and patient care goals. AMN has committed to a $5.0 million expense in staged payments. In conjunction with the investment, AMN announced that Denise Jackson also, General Counsel and Senior Vice President, has became a member of the PipelineRx Plank of Directors.A biotechnology pioneer since 1980, Amgen was among the first companies to understand the new science’s guarantee by bringing safe and effective medicines from laboratory, to manufacturing facility, to patient. Amgen therapeutics have transformed the practice of medication, helping millions of people all over the world in the fight against cancer, kidney disease, arthritis rheumatoid and other serious ailments. With a deep and wide pipeline of potential fresh medicines, Amgen remains committed to advancing science to dramatically improve people’s lives. To find out more about our pioneering technology and our vital medications, visit.. 14 million Us citizens are impaired visually A National Eyesight Institute study has discovered that although 94 % of Americans aged 12 and older have good vision, the remaining six %, or 14 million, are impaired visually.